Charles Stacey

Collaborator
DISC Type : is

President and CEO at Cerecin

United States

Overview

Charles is a former medical doctor with over 20 years of experience as a healthcare provider, entrepreneur, and investor. As President and CEO of Cerecin, he leads the development of therapies for neurological diseases like Alzheimers. He holds dual MBAs from The Wharton School and London Business School and previously worked in venture capital.

He is passionate about mentoring the next generation of innovators, serving as an Adjunct Senior Lecturer in Bioentrepreneurship at Nanyang Technological University. Charles is also a public speaker, sharing insights on brain health and medical discoveries at various institutions and events, including TEDx.

He delivered a TEDx talk on the science of brain metabolism and its potential to impact billions of patients with neurological diseases.

Personality Overview

Appreciative

Consensus Builder

Good Listener

Scenarios where both sides can come out as winners appeal to them greatly.  Unlike D or C types, they are calm as well as friendly and can give the impression of being more receptive than they actually are. They are more likely to opt for solutions that are proven in the market.

Topics They Care About

Brain Metabolism
His work at Cerecin and his TEDx talk focus on metabolic approaches to treating neurological disorders, representing a core scientific and professional passion.
Bio-Entrepreneurship
He actively mentors future innovators as an Adjunct Senior Lecturer at Nanyang Technological University and serves on the advisory panel for a BioMedTech incubator.
Healthcare Investing
Leverages his extensive experience from his prior role at global healthcare venture capital firm Inventages to guide Cerecin's strategy and growth.

Media Appearances

Cerecin CEO Charles Stacey: 'Oral Alzheimer's drug to launch by ...'. Featured in Cerecin.com

See Now

Charles Stacey – President & CEO, Cerecin - Pharma Boardroom. Featured in PharmaBoardroom

See Now

Interview: Cerecin's company progress and expansion into migraine and infantile spasms. Featured in Cerecin.com

See Now

Work History

3-2018
President and CEO at Cerecin
2-2015 - 3-2018
President and CEO (Accera Pharmaceuticals) at Cerecin
6-2024
Industry advisory panel (IAP) at co11ab Novena
12-2024
Adjunct Senior Lecturer - Bioentrepreneurship at Nanyang Technological University Singapore
10-2020 - 12-2024
Guest Lecturer at Nanyang Technological University Singapore

Education

2008 - 2010
MBA from London Business School
2009 - 2010
MBA (Healthcare) from The Wharton School

More Information

Social Presence :

Prographics :

Exp : 10 Location : United States Job Level : Leadership Designation : President and CEO at Cerecin
URL has been copied!

Insights For Selling To Charles

During A Call Or A Meeting

DO's

  • When asking them questions, sound relatable and informal
  • Use testimonials, case studies to show them why it is a low-risk, high-value decision
  • Summarize the key points at the end of the conversation

DONT's

  • Avoid unnecessary confrontation if it arises incidentally
  • Don’t ask too many questions that sound too dry and objective
  • Don’t give the impression of being unproven or risky

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Charles is

  • Relationships can sway their decisions, followed by the low risk and the presence of good evidence.
  • Will you ever get a clear answer from Charles

  • They are diplomatic when needed and rarely say no directly.

Insights For Deal Planning

    How fast (or slow) will Charles move?

  • Even if they are engaged and friendly, they can take their time to make decisions.
  • Can Charles take some risk or not?

  • They probably won’t put a lot at risk.

You And Charles

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.